Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 296, Issue 1, 2009, Pages

  Perkins, William J ^a   Warner, David O ^a   Jones, Keith A ^b  

^a Mayo Clinic

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Guanosine 3 ,5 cyclic monophosphate; Guanosine 3 ,5 cyclic monophosphate dependent protein kinase

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; NITRIC OXIDE; PHOSPHOTRANSFERASE; PROTEIN KINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY;

ANIMALS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; NITRIC OXIDE; NITRIC OXIDE DONORS; ORGAN CULTURE TECHNIQUES; PULMONARY ARTERY; SUS SCROFA; TRIAZENES; VASOCONSTRICTION; VASODILATION;

EID: 58149506373     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90318.2008     Document Type: Article

References (51)

1. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34: 245-259, 1997.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
3. Browner NC, Dey NB, Bloch KD, Lincoln TM. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J Biol Chem 279: 46631-46636, 2004.
4. Browner NC, Sellak H, Lincoln TM. Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells. Am J Physiol Cell Physiol 287: C88-C96, 2004.
5. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E, Browning DD, Eaton P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317: 1393-1397, 2007.
6. Butt E, Pohler D, Genieser HG, Huggins JP, Bucher B. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br J Pharmacol 116: 3110-3116, 1995.
7. Chang S, Hypolite JA, Velez M, Changolkar A, Wein AJ, Chacko S, DiSanto ME. Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol 287: R950-R960, 2004.
8. Chen L, Xin X, Eckhart AD, Yang N, Faber JE. Regulation of vascular smooth muscle growth by alpha1-adrenoreceptor subtypes in vitro and in situ. J Biol Chem 270: 30980-30988, 1995.
9. Cheng HC, Kemp BE, Pearson RB, Smith AJ, Misconi L, Van Patten SM, Walsh DA. A potent synthetic peptide inhibitor of the cAMP- dependent protein kinase. J Biol Chem 261: 989-992, 1986.
10. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
11. Collins SP, Uhler MD. Cyclic AMP- and cyclic GMP-dependent protein kinases differ in their regulation of cyclic AMP response element-dependent gene transcription. J Biol Chem 274: 8391-8404, 1999.
12. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 264: 1146-1155, 1989.
13. Cornwell TL, Soff GA, Traynor AE, Lincoln TM. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res 31: 330-337, 1994.
14. Dey NB, Foley KF, Lincoln TM, Dostmann WR. Inhibition of cGMP- dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cells. J Cardiovasc Pharmacol 45: 404-413, 2005.
15. Francis SH, Poteet-Smith C, Busch JL, Richie-Jannetta R, Corbin JD. Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases. Front Biosci 7: d580-d592, 2002.
16. Gao Y, Dhanakoti S, Trevino EM, Sander FC, Portugal AM, Usha Raj J. Effect of oxygen on cyclic GMP-dependent protein kinase-mediated relaxation in ovine fetal pulmonary arteries and veins. Am J Physiol Lung Cell Mol Physiol 285: L611-L618, 2003.
17. Gao Y, Dhanakoti S, Trevino EM, Wang X, Sander FC, Portugal AD, Usha Raj J. Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs. Am J Physiol Lung Cell Mol Physiol 286: L786-L792, 2004.
18. Garbers DL, Chrisman TD, Wiegn P, Katafuchi T, Albanesi JP, Bielinski V, Barylko B, Redfield MM, Burnett JC Jr. Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab 17: 251-258, 2006.
19. Geiselhoringer A, Werner M, Sigl K, Smital P, Worner R, Acheo L, Stieber J, Weinmeister P, Feil R, Feil S, Wegener J, Hofmann F, Schlossmann J. IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase. EMBO J 23: 4222-4231, 2004.
20. Hofmann F. The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280: 1-4, 2005.
21. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothe-lium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
22. 2+ in airway smooth muscle independently of cyclic nucleotides. Am J Physiol Lung Cell Mol Physiol 268: L166-L172, 1995.
23. Keefer LK, Nims RW, Davies KM, Wink DA. "NONOates" (1-substi-tuted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268: 281-293, 1996.
24. Keilbach A, Ruth P, Hofmann F. Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem 208: 467-473, 1992.
25. Kullo IJ, Mozes G, Schwartz RS, Gloviczki P, Tsutsui M, Katusic ZS, O'Brien T. Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 30: 314-320, 1997.
26. Landgraf W, Regulla S, Meyer HE, Hofmann F. Oxidation of cysteines activates cGMP-dependent protein kinase. J Biol Chem 266: 16305-16311, 1991.
27. Landgraf W, Ruth P, Keilbach A, May B, Welling A, Hofmann F. Cyclic GMP-dependent protein kinase and smooth muscle relaxation. J Cardiovasc Pharmacol 20: S18 -S22, 1992.
28. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 258: C399-C407, 1990.
29. Liu S, Ma XY, Gong MC, Shi LH, Lincoln T, Wang SX. Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med 42: 852-863, 2007.
30. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ. Vascular natri-uretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139: 1289-1296, 2003.
31. Manktelow C, Bigatello LM, Hess D, Hurford WE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 87: 297-307, 1997.
32. Meddings JB, Scott RB, Fick GH. Analysis and comparison of sigmoidal curves: application to dose-response data. Am J Physiol Gastrointest Liver Physiol 257: G982-G989, 1989.
33. Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling. J Cell Biol 160: 719-727, 2003.
34. Murthy KS, Zhou H, Makhlouf GM. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle. Am J Physiol Cell Physiol 282: C508-C517, 2002.
35. Penheiter AR, Bajzer Z, Filoteo AG, Thorogate R, Torok K, Caride AJ. A model for the activation of plasma membrane calcium pump isoform 4b by calmodulin. Biochemistry 42: 12115-12124, 2003.
36. Perkins WJ, Pabelick C, Warner DO, Jones KA. cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglu- tathione. Am J Physiol Cell Physiol 275: C468-C474, 1998.
37. Perkins WJ, Taniguchi M, Warner DO, Chini EN, Jones KA. Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide. Am J Physiol Lung Cell Mol Physiol 293: L84-L95, 2007.
38. Roos CM, Frank DU, Xue C, Johns RA, Rich GF. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats. J Appl Physiol 80: 252-260, 1996.
39. Ruth P, Landgraf W, Keilbach A, May B, Egleme C, Hofmann F. The activation of expressed cGMP-dependent protein kinase isozymes Ialpha and Ibeta is determined by the different amino-termini. Eur J Biochem 202: 1339-1344, 1991.
40. Sausbier M, Schubert R, Voigt V, Hirneiss C, Pfeifer A, Korth M, Kleppisch T, Ruth P, Hofmann F. Mechanisms of NO/cGMP-dependent vasorelaxation. Circ Res 87: 825-830, 2000.
41. Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 104: 12312-12317, 2007.
42. Smith JA, Francis SH, Walsh KA, Kumar S, Corbin JD. Autophos-phorylation of type Ibeta cGMP-dependent protein kinase increases basal catalytic activity and enhances allosteric activation by cGMP or cAMP. J Biol Chem 271: 20756-20762, 1996.
43. Soff GA, Cornwell TL, Cundiff DL, Gately S, Lincoln TM. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100: 2580-2587, 1997.
44. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 286: 1583-1587, 1999.
45. Taniguchi M, Kwak YL, Jones KA, Warner DO, Perkins WJ. Nitric oxide sensitivity in pulmonary artery and airway smooth muscle: a possible role for cGMP responsiveness. Am J Physiol Lung Cell Mol Physiol 290: L1018-L1027, 2006.
46. Thorne GD, Shimizu S, Paul RJ. Hypoxic vasodilation in porcine coronary artery is preferentially inhibited by organ culture. Am J Physiol Cell Physiol 281: C24-C32, 2001.
47. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22: 130-131, 134-138, 1997.
48. Wolfe L, Corbin JD, Francis SH. Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J Biol Chem 264: 7734-7741, 1989.
49. Worner R, Lukowski R, Hofmann F, Wegener JW. cGMP signals mainly through cAMP kinase in permeabilized murine aorta. Am J Physiol Heart Circ Physiol 292: H237-H244, 2007.
50. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N, Hirata K, Akita H, Yokoyama M. Mechanisms of reduced nitric oxide/ cGMP-mediated vasorelaxation in transgenic mice overexpressing endo-thelial nitric oxide synthase. Hypertension 36: 97-102, 2000.
51. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Ueyama T, Ishida T, Inoue N, Hirata K, Akita H, Yokoyama M. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation 101: 931-937, 2000.